Reversal of tumour drug resistance with monoclonal antibodies prospects and problems

Clinical Immunotherapeutics

Volumn 5, Issue 2, 1996, Pages 91-95

  Naito, Mikihiko ^a   Tsuruo, Takashi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; MONOCLONAL ANTIBODY;

ARTICLE; BONE MARROW TRANSPLANTATION; CANCER; CANCER CHEMOTHERAPY; HUMAN; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0030055841     PISSN: 11727039     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03259316     Document Type: Article

References (36)

1. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 1989; 58: 137-71
2. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993:62:385-427
3. Tsuruo T. Mechanism of multidrug resistance and implications for therapy. Jpn J Cancer Res 1988; 79: 285-96
4. Tsuruo T. Reversal of multidrug resistance by calcium channel blokers and other agents. In: Roninson IB, editor. Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Publishing Co., 1991: 349-72
5. Dalton WS, Grogan TM, Meltzer PS, et al. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 1989; 7: 415-24
6. Miller TP, Grogan TM, Dalton WS,et al. P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. J Clin Oncol 1991; 9: 17-24
7. Sonneveld P, Durie BGM, Lokhorst HM, et al. Modulation of multidrug-resistant multiple myeloma by cyclosporin. Lancet 1992:340:255-9
8. Kartner N, Everden-Porelle D. Bradley G, et al. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 1985; 316: 820-3
9. Scheper RJ, Bulte JWM, Brakkee JG, et al. Monoclonal antibody JSB-I detects a highly conserved epitope on the P-glycoprotein associated with multidrug resistance. Int J Cancer 1988:42:389-94
10. Hamada H, Tsuruo T. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sei USA I986; 83: 7785-9
11. Meyers MB. Rittman-Graner L, O'Brien JP, et al. Characterization of monoclonal antibodies recognizing an Mr 180,000 P-glycoprotein in muitidrug-resistant human tumor cells. Cancer Res 1989; 49: 3209-14
12. Merchetner EB. Roninson IB. Efficient inhibition of P-glycoprotein mediated multidrug resistance with a monoclonal antibody. Proc Natl Acad Sei USA 1992; 89: 5824-8
13. Arceci RJ, Stieglitz K, Brass J, et al. Monoclonal antibody to an external epitope of the human mdr\ P-glycoprotein. Cancer Res 1993; 53: 310-7
14. Schinkel AH, Arceci RJ, Smit JJM, et al. Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein. Int J Cancer 1993; 55: 478-84
15. Aihara M, Aihara Y, Schmidt-Wolf G, et al. A combined approach for purging muitidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy. Blood 1991; 77: 2079-84
16. Cenciarelli C, Currier SJ, Willingham MC, et al. Characterization by somatic cell genetics of a monoclonal antibody to the MDR1 gene product (P-glycoprotein): determination of P-glycoprolein expression in multi-drug-resistant KB and CEM cell variants. Int J Cancer 1991; 47: 533-43
17. Tsuruo T, Hamada H, Sato S, et al. Inhibition of muitidrugresistant human tumor growth in athymic mice by anti-Pglycoprotein monoclonal antibodies. Jpn J Cancer Res 1989: 80:627-31
18. Heike Y, Hamada H, Inamura N, et al. Monoclonal anti-Pglycoprotein antibody-dependent killing of muitidrug-resistant tumor cells by human mononuclear cells. Jpn J Cancer Res 1990:81: 1155-61
19. Iwahashi T, Okochi E, Ariyoshi K, et al. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK-16 directed against intrinsically muitidrug-resistant human colorectal carcinoma cell lines in nude mouse model. Cancer Res 1993; 53: 5475-82
20. Naito M, Tsuge H, Kuroko C, et al. Enhancement of cellular accumulation of cyclosporin A by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance. J Natl Cancer Inst 1993; 85: 311-6
21. Naito M. Tsuge H, Kuroko C, et al. Enhancement of reversing effect of cyclosporin Aon vincristine resistance by anti-P-glycoprotein monoclonal antibody MRK-16. Jpn J Cancer Res 1993; 84: 489-92
22. Broxterman HJ, Kuiper CM, Schuurhuis GJ, et al. Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein. Biochem Pharmacol 1988; 37: 2389-93
23. Pearson JW, Fogler WE, Volker K, et al. Reversal of drug resistance in a human colon cancer xenograft expressing MDRI complementary DNA by in vivo administration of MRK 16 monoclonal antibody. J Natl Cancer Inst 1991; 83: 1386-91
24. Rittmann-Grauer LS, Yong MA, Sanders V, et al. Reversal of vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft. Cancer Res 1992:52: 1810-6
25. Kulkarni SS, Wang Z, Spitzer G, et al. Elimination of drug resistant myeloma tumor cells lines by monoclonal anti-P-glycoprotcin antibody and rabbit complement. Blood 1989: 74: 2244-51
26. FitzGeruld DJ, Willingham MC, Cardarelli CO. et al. A monoclonal antibody-P.vcME/omrwtt.s toxin conjugate that specifically kills multidrug-resistant cells. Proc Natl Acad Sei USA 1987: H4: 4288-92
27. Dinota A, Tazzari PL. Michieli M, et al. In vitrn bone marrow purging ot multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody. Cancer Res 1990; 50:4291-4
28. Padmanabhan R. Tsuruo T. Kane SE. et al. Magnetic-affinity cell sorting of human multidrug-resistant cells. J Natl Cancer Inst 1991:83: 565-9
29. Thiebaut F, Tsuruo T. Hamada H. et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sei USA 1987: 84: 7735-8
30. Cordon-Cardo C. O'Brien JP, Casals D, et al. Multidrug resis tance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sei USA 1989: 86: 695-8
31. Chaudhary PM, Roninson IB. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991; 66: 85-94
32. Talsula T. Naito M, Oh-hara T, cl al. Functional itivuh einem of P-glycoprotein in blood-brain barrier. J Biol Cheni 1992: 267: 20383-91
33. Shirai A. Naito M. Tatsuta T, et al. Transport of cyclosporin A across the brain capillary endotheliai cell rnonolayer by Pglycoprotein. Biochim Biophys Acta 1994; 1222: 400-4
34. Schinkel AH. Smit JJ. van Tellingen O, et al. Disruption of the mouse nidi'Iu P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994:77:491-502
35. Hainada H. Miura K. Ariyoshi K. et al. Mouse-human chimeric antibody against the multidrug transporter P-glycoprotein. Cancer Res 1990: 50: 3167-71
36. Ariyoshi K. Hamada H. Naito M. et al. Mouse-human chimeric antibody MHI71 against the multidrug transporter P-glycoprotein. Jpn J Cancer Res 1992:X3: 515-21